| Nucleic acids as therapeutic agents LM Alvarez-Salas Current topics in medicinal chemistry 8 (15), 1379-1404, 2008 | 132 | 2008 |
| Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes LM Alvarez-Salas, AE Cullinan, A Siwkowski, A Hampel, JA DiPaolo Proceedings of the National Academy of Sciences 95 (3), 1189-1194, 1998 | 131 | 1998 |
| Transcriptional Analysis of the 5′-Noncoding Region of the Human Involucrin Gene (∗) E Lopez-Bayghen, A Vega, A Cadena, SE Granados, LF Jave, P Gariglio, ... Journal of Biological Chemistry 271 (1), 512-520, 1996 | 88 | 1996 |
| Dystrophin Dp71 is required for neurite outgrowth in PC12 cells R Acosta, C Montañez, L Fuentes-Mera, E Gonzalez, P Gómez, ... Experimental cell research 296 (2), 265-275, 2004 | 66 | 2004 |
| Overexpression of wild-type p53 alters growth and differentiation of normal human keratinocytes but not human papillomavirus-expressing cell lines CD Woodworth, H Wang, S Simpson, LM Alvarez-Salas, V Notario Cell growth and differentiation 4, 367-367, 1993 | 64 | 1993 |
| Inflammation-induced adverse pregnancy and neonatal outcomes can be improved by the immunomodulatory peptide exendin-4 V Garcia-Flores, R Romero, D Miller, Y Xu, B Done, C Veerapaneni, ... Frontiers in immunology 9, 1291, 2018 | 62 | 2018 |
| Differential effects of miR-34c-3p and miR-34c-5p on SiHa cells proliferation apoptosis, migration and invasion JA López, LM Alvarez-Salas Biochemical and Biophysical Research Communications 409 (3), 513-519, 2011 | 62 | 2011 |
| Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene LM ALVAREZ-SALAS, TE ARPAWONG, JA DIPAOLO Antisense and Nucleic Acid Drug Development 9 (5), 441-450, 1999 | 61 | 1999 |
| Advances in the development of therapeutic nucleic acids against cervical cancer JA DiPaolo, LM Alvarez-Salas Expert opinion on biological therapy 4 (8), 1251-1264, 2004 | 55 | 2004 |
| Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses LM Alvarez-Salas, ML Benítez-Hess, JA DiPaolo Antiviral therapy 8 (4), 265-278, 2003 | 55 | 2003 |
| Molecular approaches to cervical cancer therapy LM Alvarez-Salas, JA DiPaolo Current drug discovery technologies 4 (3), 208-219, 2007 | 48 | 2007 |
| Isolation and characterization of an RNA aptamer for the HPV-16 E7 oncoprotein JD Toscano-Garibay, ML Benítez-Hess, LM Alvarez-Salas Archives of medical research 42 (2), 88-96, 2011 | 47 | 2011 |
| MARK1 is a novel target for miR-125a-5p: implications for cell migration in cervical tumor cells MA Natalia, GT Alejandro, TVJ Virginia, LM Alvarez-Salas MicroRNA 7 (1), 54-61, 2018 | 41 | 2018 |
| Cleavage of HPV-16 E6/E7 mRNA mediated by modified 10–23 deoxyribozymes P Reyes-Gutiérrez, LM Alvarez-Salas Oligonucleotides 19 (3), 233-242, 2009 | 33 | 2009 |
| Inhibition of human papillomavirus type 16 infection using an RNA aptamer DG Valencia-Reséndiz, G Palomino-Vizcaino, JV Tapia-Vieyra, ... nucleic acid therapeutics 28 (2), 97-105, 2018 | 26 | 2018 |
| Cervical cancer, papillomavirus, and miRNA dysfunction EG Bañuelos-Villegas, MF Pérez-yPérez, LM Alvarez-Salas Frontiers in Molecular Biosciences 8, 758337, 2021 | 25 | 2021 |
| Characterization of an RNA aptamer against HPV-16 L1 virus-like particles AG Leija-Montoya, ML Benítez-Hess, JD Toscano-Garibay, ... nucleic acid therapeutics 24 (5), 344-355, 2014 | 24 | 2014 |
| Choriodecidual leukocytes display a unique gene expression signature in spontaneous labor at term M Arenas-Hernandez, N Gomez-Lopez, V Garcia-Flores, ... Genes & Immunity 20 (1), 56-68, 2019 | 22 | 2019 |
| Effect of combined antisense oligodeoxynucleotides directed against the human papillomavirus type 16 on cervical carcinoma cells MA Márquez-Gutiérrez, ML Benítez-Hess, JA DiPaolo, LM Alvarez-Salas Archives of medical research 38 (7), 730-738, 2007 | 22 | 2007 |
| YY-1 and c-Jun transcription factors participate in the repression of the human involucrin promoter LM Alvarez-Salas, ML Benitez-Hess, JA Dipaolo International journal of oncology 26 (1), 259-266, 2005 | 21 | 2005 |
